HHULY yields 0.50% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, HHULY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HHULY + PFE for your $10,000?
Hamburger Hafen und Logistik Aktiengesellschaft operates as a port and transport logistics company in Germany, rest of European Union, and internationally. It operates through four segments: Container, Intermodal, Logistics, and Real Estate. The company operates three container terminals in Hamburg; and container terminals in Odessa, Ukraine, and Tallinn, Estonia, as well as in Trieste, Italy. It also offers intermodal services that connect ports on the North and Baltic seas, and between the Northern Adriatic and its hinterland, as well as inland terminals. In addition, the company provides specialist handling, digital, and consulting and management services; and process automation, additive manufacturing, and airborne logistics services, as well as develops, rents, and manages real estate properties. The company was formerly known as Hamburger Hafen- und Lagerhaus-AG and changed its name to Hamburger Hafen und Logistik Aktiengesellschaft in 2005. The company was founded in 1885 and is headquartered in Hamburg, Germany. Hamburger Hafen und Logistik Aktiengesellschaft is a subsidiary of HGV Hamburger Gesellschaft für Vermögens- und Beteiligungsmanagement mbH.
Full HHULY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.